Skip to main content
. 2023 Jun 15;164(9):1912–1926. doi: 10.1097/j.pain.0000000000002938

Table 1.

Types of biomarkers as outlines in by Food and Drug Administration task force.

Biomarker type Definition Example
Susceptibility/risk Potential for developing a disease or medical condition APOE for Alzheimer disease
Diagnostic Detect or confirm disease/condition Rheumatoid factor for autoimmune disease
Monitoring Measured repeatedly for assessing state of the disease Prostate-specific antigen (PSA), prostate cancer
Predictive Likelihood of experiencing a favorable or unfavorable response to treatment BRCA1/2 for response to ADP-ribose-PARP inhibitors
Response Show a biological response has occurred when exposed to a treatment C-reactive protein (CRP) for effective inflammatory disease treatment
Safety Prescence of toxicity as an adverse event Creatinine for muscle damage

APOE, apolipoprotein E; BRCA, BReast CAncer Gene; ADP, adenosine diphosphate; PARP, Poly-ADP ribose polymerase.